These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 19070809)
61. A triple dose of optimism: an initial foray into triplet therapy in metastatic renal cell carcinoma. Beckermann KE; Rini BI Nat Rev Clin Oncol; 2023 Sep; 20(9):581-582. PubMed ID: 37353556 [No Abstract] [Full Text] [Related]
62. Management of metastatic renal cell carcinoma: The complexity of choice. Brown JT; Bilen MA EBioMedicine; 2019 Sep; 47():2-3. PubMed ID: 31501075 [No Abstract] [Full Text] [Related]
63. [Syndromes of shock and adaptation to renal physiopathology in course of the hypertensive phase observed in therapeutic hypotension]. JACQUET M Angeiol Ann Soc Fr Angeiol Histopathol; 1951 Oct; 58(18):33-5. PubMed ID: 14903602 [No Abstract] [Full Text] [Related]
64. What a Clinician Should Know About a Renal Replacement Membrane? Honore PM; Spapen HD J Transl Int Med; 2018 Jun; 6(2):62-65. PubMed ID: 29984198 [No Abstract] [Full Text] [Related]
65. Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma. Frangié C; Lefaucheur C; Medioni J; Jacquot C; Hill GS; Nochy D Lancet Oncol; 2007 Feb; 8(2):177-8. PubMed ID: 17267332 [No Abstract] [Full Text] [Related]
66. [The advantages of antiangiogenics in neoadjuvant and adjuvant locally advanced and metastatic kidney cancer: two case studies]. Ferrière JM; Wallerand H; Bernhard JC; Cornu JN; Rouprêt M; Ravaud A Prog Urol; 2008 Jul; 18 Suppl 4():S88-91. PubMed ID: 18706377 [TBL] [Abstract][Full Text] [Related]
67. [New treatment of metastatic renal cancer. The Danish Society of Clinical Oncology]. Sengeløv L; Geertsen PF; Ugeskr Laeger; 2007 Mar; 169(12):1117. PubMed ID: 17394828 [No Abstract] [Full Text] [Related]
68. Anti-angiogenic therapy in renal cell carcinoma: Alone, in combination, or sequentially. Figlin RA Clin Adv Hematol Oncol; 2009 Oct; 7(10):662-5. PubMed ID: 20040906 [No Abstract] [Full Text] [Related]
69. [Management of toxicities due to anti-angiogenic treatment of metastatic renal carcinoma]. Méjean A; Lebret T Prog Urol; 2008 Nov; 18 Suppl 7():S315-9. PubMed ID: 19070809 [TBL] [Abstract][Full Text] [Related]